$92.69+0.32 (+0.35%)
Hinge Health, Inc.
Hinge Health, Inc. in the Healthcare sector is trading at $92.69 with a market capitalization of $4.5B. Wall Street consensus targets $107.73 (15 analysts), implying a +16.2% move over the next 12 months. The stock is currently near its 52-week high of $95.57, remaining 62.5% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $182.31Mβ | $170.73Mβ | $154.21Mβ | $139.10Mβ | $123.83M |
| Gross Profit | $154.23Mβ | $144.03Mβ | $126.20Mβ | $97.76Mβ | $100.23M |
| Operating Income | $32.07Mβ | $27.26Mβ | -$6.09Mβ | -$580.67Mβ | $13.14M |
| Net Income | $35.13Mβ | $32.09Mβ | -$1.84Mβ | -$575.65Mβ | $17.14M |
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical reha...

Leslie maintains a $2.6 million stake after the 4% reduction.

Hinge Health Inc. (HNGE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Hinge Health, Inc. (NYSE:HNGE) raised its full-year 2026 revenue guidance to between $856 million and $860 million, well above consensus estimates of $822.16 million. The upbeat outlook follows a standout Q2 2026 performance where revenue jumped 53% year-over-year to $213 million. Non-GAAP operating income more than doubled to $62 million (a 29% operating margin), while [β¦]

As the stock market trends higher, several new issues are showing relative strength and could be big winners down the line.

Hinge Health offers an app-based artificial intelligence-enabled program for managing pain and has been growing its client base as demand surges for its products and services. It staged its initial public offering on May 22, 2025, at an IPO price of 32.